文献速递糖尿病

2型糖尿病与COVID-19重症监护死亡风险:英格兰全国队列研究

Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020.
PubMed 文献 · Diabetes Care · 2020-10-23

该研究为英格兰全国回顾性队列研究,纳入2020年3月1日至7月27日因COVID-19入住HDU或ICU的成人19,256例,采用Cox比例风险模型分析2型糖尿病与30天院内全因死亡的关系。结果显示,2型糖尿病患者的死亡风险升高(aHR 1.23,95%CI 1.14–1.32),且该相对风险随年龄增长而降低。

要点

  • 重症COVID-19患者中,2型糖尿病与30天院内全因死亡风险升高独立相关。
  • 2型糖尿病相关的相对死亡风险在年轻患者中最高,随年龄增长而减弱。
  • HDU与ICU亚组中,2型糖尿病与死亡风险的关联结果一致。

核心结论

  • 2型糖尿病可能是需重症监护的重症COVID-19患者生存的独立预后因素。
  • 在该人群中,2型糖尿病相关的相对死亡风险在年轻人中最大。

研究设计与样本

  • 英格兰全国回顾性队列研究,纳入2020年3月1日至7月27日因COVID-19入住HDU或ICU的成人。
  • 主要分析共纳入19,256例HDU和ICU入住病例,其中HDU 13,809例(平均年龄70岁),ICU 5,447例(平均年龄58岁)。
  • 采用Cox比例风险模型估计2型糖尿病相关的30天院内全因死亡,并调整年龄、性别、族裔、肥胖及其他主要合并症。

主要发现

  • 纳入病例中3,524例(18.3%)患有2型糖尿病,研究期间5,077例(26.4%)死亡。
  • 2型糖尿病患者死亡风险升高,调整后风险比(aHR)为1.23(95%CI 1.14–1.32),HDU和ICU亚组结果一致。
  • 2型糖尿病相关相对死亡风险随年龄增长而降低:18–49岁aHR 1.50(95%CI 1.05–2.15),50–64岁1.29(1.10–1.51),≥65岁1.18(1.09–1.29),年龄与2型糖尿病交互作用P=0.002。

临床怎么用

  • 在重症COVID-19救治中,应将合并2型糖尿病视为预后不良的独立风险因素。
  • 对年轻的重症COVID-19合并2型糖尿病患者,需给予更密切的监测与风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the relationship between type 2 diabetes and all-cause mortality among adults with coronavirus disease 2019 (COVID-19) in the critical care setting. RESEARCH DESIGN AND METHODS: This was a nationwide retrospective cohort study in people admitted to hospital in England with COVID-19 requiring admission to a high dependency unit (HDU) or intensive care unit (ICU) between 1 March 2020 and 27 July 2020. Cox proportional hazards models were used to estimate 30-day in-hospital all-cause mortality associated with type 2 diabetes, with adjustment for age, sex, ethnicity, obesity, and other major comorbidities (chronic respiratory disease, asthma, chronic heart disease, hypertension, immunosuppression, chronic neurological disease, chronic renal disease, and chronic liver disease). RESULTS: A total of 19,256 COVID-19-related HDU and ICU admissions were included in the primary analysis, including 13,809 HDU (mean age 70 years) and 5,447 ICU (mean age 58 years) admissions. Of those admitted, 3,524 (18.3%) had type 2 diabetes and 5,077 (26.4%) died during the study period. Patients with type 2 diabetes were at increased risk of death (adjusted hazard ratio [aHR] 1.23 [95% CI 1.14, 1.32]), and this result was consistent in HDU and ICU subsets. The relative mortality risk associated with type 2 diabetes decreased with higher age (age 18-49 years aHR 1.50 [95% CI 1.05, 2.15], age 50-64 years 1.29 [1.10, 1.51], and age ≥65 years 1.18 [1.09, 1.29]; P value for age-type 2 diabetes interaction = 0.002). CONCLUSIONS: Type 2 diabetes may be an independent prognostic factor for survival in people with severe COVID-19 requiring critical care treatment, and in this setting the risk increase associated with type 2 diabetes is greatest in younger people.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Dennis JM, Mateen BA, Sonabend R, et al. Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020. Diabetes Care. 2020. PMID: 33097559. doi:10.2337/dc20-1444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。